Skip to content

Biodesix, Inc. BDSX Price / sales

Price / sales at other companies

NeoGenomics logo
NeoGenomicsNEO
1.3×-0.5×
Veracyte logo
VeracyteVCYT
4.7×-0.3×
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
7.2×+1.4×
Personalis, Inc. logo
Personalis, Inc.PSNL
10.3×+6.7×
Guardant Health logo
Guardant HealthGH
11.2×+4.4×
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
5.9×-4.4×

Other financials

Income statement

See full
Revenue$25.6M+42.3%
Operating income-$6.2M+32.1%
Net income-$7.8M+29.8%
EPS (diluted)-$0.81+46.7%

Balance sheet

See full
Cash & equivalents$25.6M+45.3%
Total debt$71.6M+15.0%
Total equity$9.1M-17.4%
Total assets$94.6M+9.7%

Cash flow

See full
Operating cash flow-$10.2M-18.2%
CapEx$81.0K+9.5%
Free cash flow-$10.2M-18.1%

Valuation

See full
Market cap$233.52M+476%
Enterprise value$279.56M+204%

Profitability

See full
Operating margin-26%-7.5pp
Net margin-33.3%-9.3pp
FCF margin-26.8%-9.6pp

Returns & leverage

See full
Return on equity-316.5%
Debt / equity7.8×+2.2×
Current ratio2.8×+0.6×

Where this comes from

Calculated from Biodesix, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biodesix, Inc.'s price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biodesix, Inc.'s price / sales?
Biodesix, Inc. (BDSX) reported price / sales of 1.5× in Q1 2026.
How has Biodesix, Inc.'s price / sales changed year-over-year?
Biodesix, Inc.'s price / sales increased by 21.4% year-over-year, from 1.2× to 1.5×.
What is the long-term trend for Biodesix, Inc.'s price / sales?
Over 5 years (2020 to 2025), Biodesix, Inc.'s price / sales has grown at a -44.7% compound annual growth rate (CAGR), from 11.8× to 0.6×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.